Research Article
Body Image Disturbance in Acromegaly Patients Compared to Nonfunctioning Pituitary Adenoma Patients and Controls
Table 1
Participant demographics and characteristics.
| | Acromegaly
| Nonfunctioning pituitary adenoma
| Control
|
| Age | | | | Mean SD | | | | Range | 25–83 | 26–91 | 25–70 | Median | 58 | 65 | 53 | Gender | | | | Female | 13 | 6 | 14 | Male | 19 | 23 | 7 | Ethnicity | | | | NZ European | 27 | 23 | 15 | Maori/PI | 4 | 6 | 5 | Other | 1 | 0 | 1 | Relationship status | | | | Partnered | 26 | 19 | 14 | Single | 6 | 10 | 6 | Clinical characteristics | | | | BMI | | | | Mean ± SD | | | | Range | 23.1–61.7 | 18.9–44.4 | 22.1–38.8 | Obese | [50%] | [66%] | [44%] | IGF-1 levels | | | | Low | | | — | Normal | | | | High | | — | — | Initial surgery (1977–2012) | | | | TSH, transfrontal or craniotomy | | | — | Pending | | — | — | Second surgery (1978–2012) | | | | TSH | 4 | 3 | — | Pending | 1 | — | — | Radiotherapy | 10 | 10 | — | Number of current medications | | | | 0-1 | 10 | 6 | 13 | 2-3 | 8 | 12 | 4 | >3 | 14 | 11 | 4 |
|
|
Notes: missing data; low or high IGF-1 levels were defined as those outside the age and sex matched reference range.
|